Protrusive Dental Podcast

🦷 Plaque Friday™ is here!

Get 20% off Protrusive Guidance Ultimate for as long as you stay, plus 7 days free to try it. That’s every masterclass, AskJaz, verifiable CPD on hundreds of podcast episodes, and our new live series Caries, Cracks and Contact Points with Dr Ronit Patel. Use code PF26 at checkout. Ends Monday 30 November, 11:59pm UK.
👉 https://protrusive.co.uk/plaquefriday

If you showed the same bitewing to 10 dentists, would they all agree on whether to pick up the drill?
Why does the word monitoring mean nothing to a patient — and how does swapping it for active surveillance change everything from your notes to your indemnity to your government policy meetings?
Is it overtreatment to act on an E2 lesion — or is “watch and wait” actually the lazy answer dressed up as minimally invasive?
And what should you actually do with AI caries detection that flags shadows your eye doesn’t see?
In this episode, Professor Avijit Banerjee— Professor of Cariology & Operative Dentistry at King’s College London, Honorary Consultant at Guy’s & St Thomas’, and First Dean of the Faculty of Dentistry at the College of General Dentistry — sits down with Jaz for what is genuinely one of the most important caries conversations on the podcast. Part one of two.
Avijit doesn’t do soft answers. The drill-fill-bill model is broken. “Monitoring” needs to go. “Treatment planning” is antiquated terminology medics dropped twenty-five years ago. And AI in caries diagnosis? Useful — but the moment it gets things wrong, you are the one with indemnity, not the software.
What you walk away with is a framework (MIOC), a decision filter (three factors that decide whether to pick up a bur), and a vocabulary shift you can implement tomorrow. Part two covers peptides, SDF, hydroxyapatite, stepwise excavation, and managing caries in xerostomia.
 https://youtu.be/YriLo8_hXNw 
Watch PDP268 on YouTube
Protrusive Dental Pearl: Delete the Word “Monitor” from Your Vocabulary
Stop saying monitor. Start saying active surveillance.
⚠️ Active surveillance must not mean passive delay — document your reasoning, risk assessment, and what would trigger intervention.
✅ Explain it to patients as structured, proactive care: clinical checks, radiographs, risk review, behaviour support, and timely action if things change.
Key Takeaways
  • Minimum intervention oral care is bigger than minimally invasive dentistry.
  • MIOC is prevention-based, person-focused, susceptibility-related, and delivered by the whole oral healthcare team.
  • MID is only one part of MIOC: operative dentistry when a tooth actually needs intervention.
  • The four MIOC domains are: identify the problem, prevent lesions and control disease, provide minimally invasive operative care, then reassess.
  • A care plan is more useful than a treatment plan because it includes justification, prevention, behaviour change, and review.
  • Ask patients what matters to you, not just what’s the matter with you.
  • Cavitation, cleansability, and lesion activity should guide whether to intervene operatively.
  • A cavitated lesion that cannot be cleaned is much more likely to remain active.
  • Smooth surface lesions may sometimes be made cleansable without conventional drilling.
  • Restorations are not just about filling holes; they help recreate a cleansable tooth surface.
  • There is no single perfect caries detection technology — clinical examination and good radiographs remain fundamental.
  • If using NIRI, fluorescence, scanners, or AI, understand how the technology works and where it fails.
  • AI should support diagnosis, not replace clinical judgement.
  • For uncertain early lesions, triangulate: clinical findings, radiographs, risk, technology, and patient factors.
  • Proximal resin infiltration has a role in the right patient and situation, especially as part of a wider prevention-led strategy.
Highlights of This Episode
  • 00:00 Teaser 
  • 02:17 Protrusive Dental Pearl: Active Surveillance, Not Monitoring 
  • 09:14 Minimum Intervention Oral Care vs Minimally Invasive Dentistry 
  • 11:28 Core Principles of MIOC 
  • 11:48 Domain 1: Identify the Problem 
  • 12:46 Domain 2: Prevention of Lesions and Control of Disease 
  • 13:18 Microinvasive Care Options 
  • 14:41 Domain 3: Minimally Invasive Operative Dentistry 
  • 16:38 Why “Active Surveillance” Matters 
  • 18:24 MIOC as a Practical Framework 
  • 19:43 Applying MIOC in Patient Communication 
  • 22:38 Sustainability & Salutogenesis 
  • 29:05 When to Pick Up a Drill 
  • 30:23 Biofilm as the Engine of Caries 
  • 31:33 Purpose of a Restoration in Caries Management 
  • 36:13 Caries Detection Technologies 
  • 42:44 Watch and Wait vs Detect and Manage 
  • 01:02:52 Outro
Professor Avijit Banerjee’s recommended reading and ongoing work:
  • New textbook: A Clinical Guide to Advanced Minimum Intervention Restorative Dentistry (Banerjee A., Elsevier, 2024) — the most comprehensive single reference for modern MIOC and MID.
👉  uk.elsevierhealth.com (ISBN 978-0-443-10971-3)
🦷 Interested in Proximal Resin Infiltration?
Loved This Episode? Try this next:
Is Caries Detector Dye BS? – PDP138
#PDPMainEpisodes #BreadandButterDentistry 
Listen & Earn CPD
This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance.
This episode meets GDC Outcomes A and C
AGD Subject Code: 250 Operative Dentistry (Caries Detection and Prevention)
Aim & Learning Outcomes
Aim: To equip dental practitioners with a contemporary, evidence-informed framework for the diagnosis and non-operative or minimally invasive management of dental caries — with a particular focus on the decision-making that determines whether operative intervention is justified.
Learning Outcomes — by the end of this episode, dentists will be able to:
  • Describe the four underpinning principles and four clinical domains of Minimum Intervention Oral Care (MIOC), and articulate the difference between MIOC and minimally invasive dentistry.
  • Apply a structured decision filter — incorporating cavitation, cleansability, and lesion activity — to determine whether a carious lesion requires operative intervention or microinvasive/non-operative management.
  • Differentiate between passive monitoring and active surveillance, and use appropriate language in clinical communication, care planning, and contemporaneous notes

What is Protrusive Dental Podcast?

The Forward Thinking Dental Podcast

SEO METADATA

SEO TITLE:
Modern Caries Management Part 1: MIOC, Active Surveillance and Resin Infiltration | PDP268

META DESCRIPTION:
Prof Avijit Banerjee explains MIOC vs MID, active surveillance, when to drill, caries detection tech, AI on radiographs and proximal resin infiltration.

URL SLUG:
modern-caries-management-part-1-mioc-mid-active-surveillance

PRIMARY TOPIC:
Modern caries diagnosis and minimum intervention oral care

SECONDARY SEARCH TOPICS:
- Minimum intervention oral care (MIOC) vs minimally invasive dentistry (MID)
- Active surveillance instead of monitoring caries
- When to restore a carious lesion: cavitation, cleansability and activity
- Near-infrared imaging (NIRI) and fluorescence caries detection
- AI caries detection on radiographs
- Proximal resin infiltration with Icon
- E1, E2 and D1 lesions: sealant or resin infiltration?
- Salutogenesis and personalised care planning in dentistry

A PRACTICAL GUIDE TO MODERN CARIES MANAGEMENT PART 1: MIOC AND MID
THE PROTRUSIVE DENTAL PODCAST, EPISODE PDP268
HOST: DR JAZ GULATI
GUEST: PROF AVIJIT BANERJEE

EPISODE SUMMARY

In part one of this two-part series on the Protrusive Dental Podcast, Dr Jaz Gulati is joined by Prof Avijit Banerjee, professor of cariology and operative dentistry at King's College London. Prof explains the difference between minimum intervention oral care (MIOC), a whole-team delivery framework with four clinical domains, and minimally invasive dentistry (MID), which is just one of those domains. He makes the case for replacing "monitoring" with active surveillance, treatment plans with personalised care plans, and "What's the matter with you?" with "What matters to you?"

They then get clinical. Prof explains the three factors that decide whether to pick up a drill: cavitation, cleansability and activity. He gives his honest view on caries detection technologies such as NIRI and fluorescence, and on AI for reading radiographs, urging clinicians to understand their kit and to triangulate their findings. He gives proximal resin infiltration a big thumbs up for the right patients and explains where it fits alongside sealants. Jaz's Protrusive Dental Pearl is to stop saying "monitor" and start practising active surveillance.

IN SHORT

This episode explains how to diagnose early caries and decide when to intervene. Prof Avijit Banerjee's approach is to detect early and manage actively, rather than watch and wait: restore when cavitation stops the patient cleaning the lesion, triangulate uncertain findings, and use micro-invasive options like sealants and resin infiltration for early lesions.

KEY TAKEAWAYS

- Jaz's pearl: replace "monitoring" with active surveillance, which better describes what we do and reassures patients.
- MIOC is a framework with four domains: identify the problem, prevent lesions and control disease, minimally invasive operative care, and reassessment and recall.
- Prof's three factors for intervening are cavitation, cleansability and lesion activity.
- A cavitated buccal cervical lesion can often be saucerised and kept clean by the patient, rather than drilled and filled.
- No caries detection device gives perfect accuracy, so learn how your technology works and calibrate yourself on obvious lesions.
- When in doubt about an early lesion, triangulate: careful clinical examination, good radiographs, other detection devices and, if you wish, AI.
- Prof gives proximal resin infiltration a big thumbs up for the right patients, with the sweet spot around E1 to E2 lesions.
- Ask patients "What matters to you?" and write justifications into a personalised care plan.

QUESTIONS ANSWERED IN THIS EPISODE

1. What is the difference between MIOC and MID?
2. Why should we say active surveillance instead of monitoring?
3. When should you pick up a drill for a carious lesion?
4. Is there one technology that can level up caries diagnosis?
5. Does proximal resin infiltration work, and is it worth the fiddliness?
6. Which lesions are suited to resin infiltration, and which to a fissure sealant?
7. How trustworthy is AI caries detection on radiographs?
8. What is salutogenesis, and how does it change the way we talk to patients?

IN THIS EPISODE

1. Introduction: a practical guide to modern caries management
2. Protrusive Dental Pearl: stop monitoring, start active surveillance
3. Meet Professor Avijit Banerjee
4. MIOC vs MID: the four domains of minimum intervention oral care
5. Why the framework matters: communication, the whole team and sustainability
6. Salutogenesis: ask "What matters to you?", and plan care, not treatment
7. Caries into dentine: cavitation, cleansability and activity
8. Caries detection technology: NIRI, fluorescence and training your own brain
9. Proximal resin infiltration: detect and manage, don't watch and wait
10. The sweet spot: E1, E2, D1, and sealant vs resin infiltration
11. A word from our partner: DMG Icon Proximal offer, webinar and hands-on course
12. AI caries detection and the power of triangulation
13. Justify your decisions, talk your think, and a peptide cliffhanger

CHAPTER 1: INTRODUCTION: A PRACTICAL GUIDE TO MODERN CARIES MANAGEMENT

JAZ:
This is a huge one, Protruserati. Over the next two episodes, I've got a world-renowned professor of cariology for you, Professor Avijit Banerjee. He literally writes the books on caries. What Prof doesn't know about caries is not worth knowing. It's something we fight every day. As general dentists, we diagnose and manage caries deep in the trenches of our patients' mouths.

It's dentistry 101. It's the most prevalent disease in the world. Yet there's still so much confusion about how to diagnose and manage it, and this two-part series will give you frameworks and clarity. I'm so excited to put these two episodes out for you. In part one, we find out whether there's anything new, contemporary or worthwhile in caries diagnosis.

This matters because our diagnosis dictates our management. To drill or not to drill is always the question. And the funny thing is that if you show different dentists the same radiograph, you'll get different answers about whether to take a drill to that tooth. Should we be more unified in our consensus and diagnosis?

And at what level of diagnosis should we undeniably be picking up the bur, versus reaching for something else?

CHAPTER 2: PROTRUSIVE DENTAL PEARL: STOP MONITORING, START ACTIVE SURVEILLANCE

JAZ:
I'm going to give you the Protrusive Dental Pearl, inspired by this episode, straight away. I've already implemented it. The pearl is that we're no longer going to use the term "monitoring".

We don't monitor our patients for caries. We don't watch. We don't monitor. Delete those terms now. From now on, we're implementing active surveillance. You'll see why this small shift in terminology is so powerful. As a patient, "monitor" and "active surveillance" mean two different things.

And the term better reflects what we actually do. We take radiographs, we check extra carefully clinically, and we triangulate all the data, which you'll hear more about in this episode. We also find out whether caries detection in intraoral scanners is any good, and whether Professor Banerjee likes AI caries diagnosis.

Is it a boon or a bane? Another huge takeaway for me, which you must listen to, is his view as a professor on proximal resin infiltration. Is it a fad, or does it scientifically work and hold up? I actually know very few clinics that offer proximal resin infiltration at the moment.

Is that slow uptake justified, or should we be offering proximal resin infiltration to every patient with early caries? Then we start touching on peptides, which I didn't know much about, but we'll save that for part two. This episode will give you so much more clarity on frameworks and protocols, starting with caries diagnosis and how far caries detection has progressed.

Please share this episode far and wide, my dear friends. It's a truly universal episode, and I'm convinced it's going into the Protrusive Hall of Fame. When you feel those light bulbs going off, don't forget to hit that subscribe button, and I'll catch you in the outro.

CHAPTER 3: MEET PROFESSOR AVIJIT BANERJEE

JAZ:
Professor Avijit Banerjee, it's such a huge pleasure to have you on the podcast.

It's been a long time coming, to be honest. I don't know how much of this you've seen, but behind the scenes there's been so much excitement in the Protrusive community. When I announced it, I didn't drop your name. I just said a professor of cariology was coming on the show, and even from that, everyone was like, "Whoa, I'm really looking forward to this."

When I dropped your name, they said, "Okay, this is going to be epic." So we're really looking forward to it. What you've contributed to cariology, dentistry and education is immense. For the very few listeners who may not have heard of you, please tell us about yourself, your current positions and your passion.

PROF AVIJIT BANERJEE:
Thanks, Jaz. It's an absolute pleasure to be here, and I really appreciate being invited. I think what you do with your community is immense, and it's a privilege to be a small part of it. I work at King's College London, in the Faculty of Dentistry, Oral and Craniofacial Sciences.

It used to be Guy's, but now it's King's College. I've been there pretty much all my professional life. I trained there, I'm still working there now as a chair, and I'll probably retire there, who knows? As you rightly say, my clinical and academic interest has always been cariology and operative dentistry.

After working through various DCT and house jobs, a master's, a PhD and specialist training, I'm currently professor of cariology and operative dentistry there. I wear multiple other hats. I'm an honorary consultant in restorative dentistry at Guy's and St Thomas' hospitals.

I'm an honorary clinical adviser to Jason Wong, the current Chief Dental Officer for England, and I'm getting more and more involved with national policy, which I'm sure will come up in this discussion. I'm currently dean of the Faculty of Dentistry at the College of General Dentistry, CGDent, the new college for primary care practitioners and the oral healthcare team, so it's a real privilege and an honour to be the first dean of that faculty.

I'm the oral and dental specialist lead for the South London Research Delivery Network, which is part of the NIHR and supports research across the UK. Linked to that, I'm currently president of the British Society for Oral and Dental Research, BSODR, where we're actively looking for more team members and practitioners to get involved in research, especially in primary care.

And last but not least, I'm now editor-in-chief of the British Dental Journal portfolio, the strategic editor of all six journals in it. So I'm pretty busy, an eight-day week, but it's really good fun.

JAZ:
I can vouch for that. One thing you didn't touch on much is how many publications you have and how involved you are in research. Obviously, we could go on and on. Prof, do you remember the first time we met?

PROF AVIJIT BANERJEE:
We've certainly worked together, and we've published together, that's for sure. I'm just trying to think how many years ago that was now. It's probably frightening. I don't really want to know.

JAZ:
It was over 10 years ago. Maybe 12.

PROF AVIJIT BANERJEE:
I was going to say about 12 or 13. Exactly.

JAZ:
You probably don't remember, because you're the professor. But as a student, you remember every scolding. It wasn't quite a scolding, but let me tell you what happened.

I knocked very timidly on your office door, 'cause, oh my God, I was about to meet Prof Avijit. I had a proposition for you. I wanted to work with you. You kindly let me in, sat me down, and asked about my interests and what I wanted to do.

I said, "Look, I want to publish something in Dental Update." And you set me a task. You said, "Jaz, do this for me. It'll probably take you 15 or 20 minutes. I want you to look at what's been published in Dental Update in the last 10 years, and bring it back to me."

Fast-forward four hours in front of a laptop, and I can tell you I was almost cursing your name. I don't know whether you knew it, but that was no 15-minute task. It took four hours. Anyway, I presented it to you, you were really impressed, and that's how we agreed to do the RBB paper.

And it was so nice of you to pass it on to Trevor Burke, who sent me a handwritten letter saying, "That was really good data. Thank you so much." So I just wanted to tell you how intimidated I was the first time I met you, but it was an honour and a privilege to work with you.

And now I get to talk about caries with you. Let me tell you a bit about the audience. We have all ages, from students all the way to retired dentists who just like hearing about dentistry. So it's a whole spectrum, and I think everyone has something to learn today.

CHAPTER 4: MIOC VS MID: THE FOUR DOMAINS OF MINIMUM INTERVENTION ORAL CARE

JAZ:
I have so many questions, and we've set aside the time, so I'll start with some definitions. Yes, we could talk about policy, which you touched on, but I really want to get into the small details and how they've changed over the years. So let's start with the bigger picture.

MIOC and MID. What do they stand for, and what do they mean to you? When you write them, a dentist may interpret them a certain way. But I want to hear from you how they were intended. What was the message behind them?

PROF AVIJIT BANERJEE:
Great. Thank you. It's a really, really important question, because we're shifting the dial in how we manage caries and look after patients. Let's cut to the chase. We've been doing too much traditional work for too long, which has primarily been seeing disease in the mouth, with our eyes, with loupes, with whatever detection technology.

We see cavities, we salivate, and we want to drill them and fill them. And our systems pay for that. That's been going on for decades and decades. I'm not saying it's wrong, but it isn't actually looking after patients and treating disease. It's literally filling holes and treating the consequences of disease.

It's really just treating the symptoms. These terms, principles and philosophies have been around for a long, long time. But because people aren't sure what they mean, which is exactly where your question is heading, the words get muddled up and used interchangeably.

And so they lose their effect. Over the last decade or so, as I've done more policy work, it became really clear when explaining things to different stakeholders, funders, policymakers, government, the NHS, whoever, that people aren't sure what we do in dentistry. It's quite frightening.

It's really quite frightening. So I looked at what was out there. It's basically reinventing the wheel, but to clarify things a little, which is why your question is so pertinent. You've heard of minimum intervention and minimally invasive. These terms are out there.

Pretty much everybody bandies them around: MID, minimum intervention dentistry, or minimally invasive dentistry. Practically the whole profession and all stakeholders use them interchangeably, but they're not the same. So, minimum intervention oral care. Get rid of "dentistry", because it's about the mouth, not just the teeth.

Minimum intervention oral care, or MIOC, M-I-O-C, is a delivery framework, and it's common sense. It's prevention-based. It's person-focused, so individualised. It's susceptibility-related. And it's delivered by the oral healthcare team, not the dental team, the oral healthcare team.

Those are the four underpinning principles, and within them, minimum intervention oral care has four simple, interlinked clinical domains. First, the clinician needs to identify the patient's problem. You do your examination, history taking, detection, diagnosis, special investigations and so on.

You do your risk and susceptibility assessments, and pull it all together to develop, not a treatment plan, because these are antiquated terms that need to be thrown out. Our medical colleagues haven't used this terminology for 25 years, but we still do.

It's a personalised care plan, not a treatment plan, and I'll come back and explain the difference a bit later. You develop your personalised care plan, and you stage it, so it happens in phases. That's the first domain, and it can be done by all members of the oral healthcare team, not just the dentist.

Dental hygienists, dental therapists, extended-duties dental nurses, reception staff, practice nurses: everybody gets involved in a different way. The second domain is prevention of lesions and control of disease. Again, terminology is everything. You said you wanted to get into the nitty-gritty, and I'm pleased you did.

It's prevention of lesions and control of disease. The disease, caries, occurs in the biofilm, in plaque. You don't prevent plaque, so you don't prevent the disease. You control it. It's a balance. That's what you were taught at dental school: the seesaw.

But you can prevent the consequences of the disease, which are the lesions, from a white spot lesion all the way through to a dead pulp. So you prevent lesions and control disease, and that's all about behaviour management of the patient, and also of the profession, in learning to do the right thing.

There's primary prevention, which happens at home: the patient does the work with a toothbrush, floss and toothpaste, and by controlling their diet. Then we might also include secondary prevention measures. When early disease starts, we can reverse it, and for that we use micro-invasive technologies and protocols.

By that I mean preventive sealants, therapeutic sealants and sealant restorations. It could be resin infiltration technology. It could even be peptide infiltration and mineralisation technology. These are some-

JAZ:
That's the only one I don't know anything about, but we'll touch on it later.

PROF AVIJIT BANERJEE:
Absolutely, I'll come back to that. These are micro-invasive interventions the team can deliver to the patient in clinic. By micro-invasive, I mean you're working at a micron level, in the porosities of the tooth.

JAZ:
Do fluoride varnish and silver diamine fluoride fall within this?

PROF AVIJIT BANERJEE:
They're linked to it, absolutely. You're absolutely right. The third domain of minimum intervention oral care is minimally invasive operative dentistry. The patients we see with holes in their teeth need treatment: fillings, excavation, whatever operative intervention is appropriate.

But it has to be done minimally invasively. That's where MID, minimally invasive dentistry, comes in. The fourth and final domain is reassessment and recall. We often do the fillings, the patient walks away, and we don't see them again for six months, 12 months or even longer.

Actually, the most critical part of treating and managing disease is getting the patient back, reviewing the work you've done, and reviewing their behaviour change and whether they're following our advice. And another term that I think should be thrown out is "monitoring".

We use it all the time, but it's a passive throwaway term. It means nothing. A much better term is active surveillance. When I first heard this terminology at a US paediatric caries summit, from my US colleagues, I immediately thought of FBI agents.

Black suit, white shirt, black tie, shades, earpieces, tapping into your phone and reading your emails. Metaphorically, that's what we should be doing with our patients. We should be getting involved, actually assessing and checking, not just passively looking in the mouth, saying, "Yeah, everything's fine," and moving on.

JAZ:
Can I just add something? Some people listening may think, "Ah, but Prof, this is just semantics." But I think semantics are important, because they define how you approach something. And the reason I like this shift from monitoring to active surveillance is that I literally emailed a patient yesterday, after looking at her radiographs from when I worked at a previous practice and her most recent ones, and said, "Okay, don't worry.

"We don't need any active intervention. You don't need to book anything in." But I said, "I'm watching this one like a hawk." That sums it up better than "we're going to monitor it". It's much nicer for the patient to read. If I'm the patient, reading my care plan, "monitor" versus "active surveillance"... the second just feels better, like I'm in safe hands.

PROF AVIJIT BANERJEE:
You've hit the nail on the head. Not only is it a better description of what we do, as you've just highlighted, but if we want to change policy, people like me and others have to go to government, to people who don't understand what we do, and you've just nailed it.

They're patients too. "Oh, we're just monitoring you" means nothing to anybody, because how do you define it? Whereas active surveillance means double-checking and periodically checking their susceptibility to disease, and obviously checking for new lesions, progressing lesions or reversing lesions.

It can be done through teledentistry. COVID had many negatives a few years ago, but one of the positives, I think, is that we can now do this sort of thing, which people really didn't do six or seven years ago. We've got to think outside the box in how we deliver this care, this active surveillance and supportive care.

So those are the four domains: identifying the problem, prevention and control, minimally invasive operative dentistry, and recall, reassessment and active surveillance. That's what makes up minimum intervention oral care.

CHAPTER 5: WHY THE FRAMEWORK MATTERS: COMMUNICATION, THE WHOLE TEAM AND SUSTAINABILITY

JAZ:
I think I speak for our listeners and viewers when I say that, when it's presented this way, some may think, "Do we really need to add all these words?"

But it puts a frame around it, and reminds us that it's not just drill, fill and bill. It really sets out the framework. And I think most of the dentists who tune in to this podcast in particular are, reassuringly, already doing this.

It's just a nice reminder, because we need the patient to play their part, then we need to do the prevention we can, at the micron level, like you said, then the operative care that's required, and then the active surveillance afterwards.

It's a good reminder and reassurance, 'cause this is really what we were taught at dental school. It's just a nice, clear pathway that moves us away from drill, fill, bill, and "treatment plan".

PROF AVIJIT BANERJEE:
Exactly. You've summarised it perfectly. As I said at the beginning, this is nothing new. It's just putting it into boxes, or under headings, which allows us to use our teams more effectively, and to provide the best care, which this clearly would. And I completely agree with you: anybody listening is probably already doing this, because they're interested.

JAZ:
If there's a change for me, from however many minutes we've been recording so far, it's this. When I learn something, or something gets validated, unless you act on it and look at your protocols, it's wasted knowledge.

What you've inspired me to do is, when I send my Loom video plans or letters summarising patients' care plans, instead of saying, "Hey, you need to come in for restorations in this quadrant," I'll say, "Make sure you do the five things I told you about in clinic for prevention.

"We'll look at sealants," and so on. Just breaking it down, not to make it longer, but so the patient understands more about what's going on in their mouth, that they have the power to prevent this, and that it's not just, "You've got to come in for this intervention." It puts the philosophy you described into practice, even in your communication.

PROF AVIJIT BANERJEE:
Again, absolutely spot on. That's the whole point, because dentists are probably doing a lot of these things in their heads, but perhaps not in a nicely structured order. They're not necessarily writing them down.

They're not necessarily communicating them. And I repeat, with the changes in NHS policy, and in private practice for that matter, this ties everything together, so you can start to account for your time, your costs and your business models. Even though I'm a clinical academic, I've worked in practice for many years.

I've never run a practice, and I'm not claiming to be a business person, but I see the value of the business side. The beauty of this is, number one, patient care, obviously. That goes without saying. Number two is what you've just said: professional validation, doing the right thing, and itemising things.

And thirdly, there's the whole idea of running the business with the right business model, using the right members of the oral healthcare team, and getting all the different stakeholders, patients, the profession, everybody, to value what we're trying to do.

You said at the beginning that you could argue this is semantics, or playing with words. But I mentioned the dental team a few minutes ago. I've asked politicians, people who are in charge of what we do, who the members of a dental team are.

They say the dentist, the dental nurse, and that's it. People forget about reception staff, clinical dental technicians, dental hygienists, dental therapists, extended-duties dental nurses, oral health practitioners and so on. And they're equally, if not more, valuable than the dentist in all of this, for the majority of the patients we treat.

So the MIOC framework, I repeat, isn't complicated. It's exactly what you were taught at dental school. I've just given it labels we can hang all the principles you mentioned on, from diagnosis and treatment through to communication and empowering our patients.

And something else this fits into, which we mustn't forget, is sustainability: environmental and socio-economic. The drill, fill, bill model is not sustainable in any shape or form.

I'm privileged to be chairing sessions linked to COP30 and COP31, and we're developing the Global Oral Health Climate Action Conference for November. All of this is playing a part now. The WHO is talking about it, so it's building momentum.

CHAPTER 6: SALUTOGENESIS: ASK "WHAT MATTERS TO YOU?", AND PLAN CARE, NOT TREATMENT

PROF AVIJIT BANERJEE:
And there's something else that's really key, especially generationally, for the patients we'll be treating as we get older. It's called salutogenesis, which you may or may not have heard of. The concept has been around for many years. Rather than looking at negatives and problems to overcome, the argument is to look at improving health, in our case oral and dental health, through positive solutions and promotion.

When a patient comes into your clinic and sits down, we essentially ask them, "What's the matter with you? How can we help you?" That already has a negative connotation. The best way to summarise salutogenesis is to change that question to, "What matters to you?"

It's a subtle, psychological point, but it shifts the dial again, and it goes back to shared decision-making. You take the patient, or caregiver, with you on the journey. When you do that, you're actually achieving behaviour change without even realising it, because you're empowering and facilitating the patient to value their oral health. Most people don't realise how important oral health is to general health.

We do, as a profession, but very few other people do. By doing this, your communication gets better. The patient can discuss care plans with you. You're still in charge, and you still make the clinical decisions, of course. But you're doing it in a much nicer way, with care planning, not treatment planning, and the difference is that with care planning, you have justifications written down.

Why are you doing that filling? Why are you doing the endo? Why are you doing active surveillance rather than intervening?

JAZ:
And all those whys link back to what matters to them.

PROF AVIJIT BANERJEE:
Correct. Bingo. And so it all fits. It sounds very complicated when I talk about it, but you're already doing it.

As you said earlier, we're just structuring it to make it easier, and we're talking to electronic patient record systems to make it easier to record. That's the shift, the direction we're going in.

JAZ:
I love this so much. I'm so glad you mentioned communication, because the biggest thing you'll see when you start doing this is how much more effectively you communicate with patients. You talk in their language, because they've just told you what's important to them.

Then you can make better joint decisions and better recommendations, 'cause we're allowed to recommend a plan to the patient based on what they say.

PROF AVIJIT BANERJEE:
Absolutely.

JAZ:
So when they tell you, "This is what matters to me," you can say, "Because this matters to you, I'm not going to recommend a denture, because that could cause other issues." It helps you become clearer and more confident in your recommendations.

PROF AVIJIT BANERJEE:
Absolutely.

JAZ:
The other communication point I want to touch on is a hat tip to Dr James Goolnik, who's involved with Kick Sugar. He taught me, probably 15 years ago, that when you're doing an oral cancer examination, you tell the patient, "I'm just going to check for oral cancer."

It's something we already do, but when you tell the patient, they say, "Oh, no one's ever done that before." But actually, the last 50 dentists all did it. No one ever said it.

PROF AVIJIT BANERJEE:
Correct.

JAZ:
So again, it's all part of communication. There's a lot to take from this framework in how we write and speak to our patients. It goes beyond the management of the disease.

It's a bigger wrapper around communication, and around the importance of oral health that we convey to the patient.

PROF AVIJIT BANERJEE:
Again, you've taken the words out of my mouth. That's precisely the point. I'm a huge advocate of using the oral healthcare team.

That's why people are trained and have a scope of practice. And practice business models can be tweaked and improved to incorporate this, so the whole team is singing from the same hymn sheet, so to speak.

CHAPTER 7: CARIES INTO DENTINE: CAVITATION, CLEANSABILITY AND ACTIVITY

JAZ:
Let's talk about something clinical: caries into dentine. Obviously, a radiograph isn't your diagnosis. It's just one source of data that helps inform it. There's your clinical diagnosis and your imaging diagnosis, and you have to match them up and look at the patient as a whole.

But thinking about radiographic diagnosis, when you see a radiolucency into dentine, my generation was taught that back in the day, we used to see that and drill in. But when I was taught, it was, "No, no, we don't need to do that. We now need to check whether the surface has cavitated, because a cavitated surface is a reason to intervene."

Has anything changed there? Have we become even more conservative, so that it has to be a lot more cavitated? Or is it still the same? Any guidance on what I was taught?

PROF AVIJIT BANERJEE:
Essentially, what you were taught was correct. We're fine-tuning a little, but that's all.

Ultimately, when you do your examination, loupes or some form of magnification would be ideal. I appreciate it can't always happen, but I think in this day and age there's less and less excuse not to use them.

JAZ:
I don't trust anyone without loupes, Prof. I advocate that all the time on here.

PROF AVIJIT BANERJEE:
Absolutely. So, good loupes, good lighting and so on. The argument has always been that we look at the progress of the lesion. You can look at its progress histologically and clinically, and you can look at its progress radiographically, which is still histological, but using the radiograph.

There are of course other detection devices, and they can work very effectively, but I think most of the evidence over the years has shown that clinical examination coupled with radiographs is still our gold standard. I do caveat that, though: we have technologies that are getting better, optical technologies and fluorescence technologies.

The point is, lesions literally progress from a healthy tooth to the earliest white spot enamel lesion, with porosity that spreads through the enamel, hits the EDJ, and then starts to spread into dentine. We're looking at that, but we're also looking at what's happening on the tooth surface: the roughening of the white spot lesion as demineralisation really takes effect, and ultimately the breakdown of the tissues, and then cavitation.

So, to cut to the chase, if you want to pick up a drill and do something, the first factor to think about is cavitation. Can you see a hole? Of course, you can also have micro-cavitation, which is harder to see. Depending on the radiographic depth, you can still seal some of those if they're in the outer third of dentine.

But if there's obvious cavitation, where you can see dentine at the bottom of the hole, think about what's going to happen. That hole will fill with plaque, with biofilm, and the patient can't get a toothbrush, floss or anything into it to clean it out.

As we all know, the biofilm then changes. It becomes dysbiotic, an ecological change in the microbiome, so it becomes cariogenic. The way I describe it to my students is that it's as though you've turned the engine on and it's revving away. The process is happening. And because the biofilm is growing and stagnating more, you've now put the car into first gear and it's moving.

So the process is active: the caries process is happening. Cavitation leads to cleansability, meaning can the patient clean it? And that leads to activity of the lesion. Those are your three factors. That's for an occlusal or a proximal lesion. Now, what if you've got a buccal cervical lesion?

Think about the location. With a buccal cervical lesion, and this is so important because we're talking about whether to go in with a drill, you may still have cavitation. Well, you'll potentially still have cavitation. So does that mean you pick up a drill and drill a hole?

Absolutely not. On a smooth surface like a buccal cervical, you can potentially make the lesion cleansable without much drilling. You can saucerise the cavity, make it easy for the toothbrush to get in, and then educate the patient on how to clean it with a toothbrush and a bit of toothpaste.

And guess what? If the patient disrupts that biofilm, the lesion arrests within literally two or three weeks, because the engine of the caries process is the biofilm. So for us, operative dentistry isn't about the lesion. It's actually about the biofilm, if we're actually managing disease.

Of course, if you've got big holes in teeth, there will be structural, functional and aesthetic issues, and that's another reason for filling teeth, obviously. But what people forget is that the main reason for putting a restoration in the tooth is to make the contour and surface of that tooth cleansable again for the patient.

Then the priority goes back to primary prevention: educating the patient about using a toothbrush properly, floss or whichever aids, toothpaste and so on. It always falls back on what the patient does at home.

CHAPTER 8: CARIES DETECTION TECHNOLOGY: NIRI, FLUORESCENCE AND TRAINING YOUR OWN BRAIN

JAZ:
Thank you for answering that so succinctly. You raised a couple of nuances there that I'd love to explore. One is technology. Magnification, lighting and radiographs are the gold standard. But if someone came to you and said, "I have a busy practice with seven surgeries.

"We'd like to give our patients a higher standard of caries diagnosis," which one tool might you recommend? For example, the iTero has NIRI. I use it sometimes, but to be very honest, I don't know how effective it is, or whether it's gimmicky.

There are other fluorescence tools too. What's the one thing you think could level up our caries diagnosis, in addition to good clinical observation and radiographs?

PROF AVIJIT BANERJEE:
Honest answer: I don't think there is one at the moment. Part of the problem is that we live in a world where we want lots of evidence and proof that something is better than something else before we use it and make it the norm.

There are lots of different technologies. You're talking about NIRI, near-infrared imaging, on your iTero. There are fluorescence and optical technologies out there. DIAGNOdent, for example, has been around for many, many years. And there are lots of iterations and variations of these technologies.

So they exist. The physics is very clever, but it isn't foolproof for any of them. No technology will give you 100% sensitivity and 100% specificity for a disease. Not one. So you always have to use your noggin to interpret what the device is telling you, and that interpretation is key.

But what I will say is this. If you're doing your clinical examination carefully, with magnification and good lighting, and taking good-quality radiographs, and now with AI, which can potentially help us as it machine-learns the subtle changes in early lesions, then you can pick one of the technologies.

There will always be evidence that the technology works to a degree. But a lot of those experiments are done in a laboratory, or in very controlled trials in patients, which they have to be. That's not a criticism. That's life.

The difficulty with translating that data into your practice, or mine, is that we don't have a controlled environment. We have a patient, with all the different variables, so you have to adapt and understand the technology. Sorry, it's a very long-winded answer, but my answer is that it's not about which specific technology.

If you want to use technology, use it. I'm not saying don't. What I'm saying is really learn and understand how it works, in depth. Learn some physics, and understand how the optics, or whatever it is, interact with the histology to give you the data you're getting, whether it's an image, a number or something else.

Once you know how it works, you'll start to work out its limitations. Then you can interpret the data sensibly, for that tooth surface, in that mouth, in that patient, in that clinic, on that day, with that weather and everything else.

In your notes, you write down what you found and how you interpreted it. Again, you discuss it with the patient, and it goes back to what we were saying about MIOC and pulling it all together. It's not guesswork. But I don't want to say use product X or technology Y, because people sometimes hang on those words and go and do it without really thinking it through. And that's what I want our colleagues to do: think about what we're doing.

We're all very bright people, and whatever we use, we should really work out what's good about it, what's bad about it and how it works.

JAZ:
So my takeaway is this. I've got an iTero, and iTero has a huge market share, so a lot of my colleagues have one too. It's okay to use, but I need to go away and really understand exactly what the near-infrared image I get actually is.

And what are the disadvantages? We owe it to our patients to do that. That's why I haven't been using it: I haven't really understood it, so I just use my radiographs and clinical diagnosis. But if you're going to use it, make sure you know the ins and outs. I think that's a good way to do it.

It opens up whichever technology you want to use. Just make sure you're using it in the correct way.

PROF AVIJIT BANERJEE:
Absolutely. You'll obviously do a bit of reading about it, because there will be publications and writing on it that's been done properly.

But what people also forget is that once you've got the kit, you start to calibrate yourself. If you're going to use it for caries or white spot lesion diagnosis, find some patients where you can clearly see the white spot, zap it with your scanner, and start to build up.

You know how we talk about AI, and how you have to feed it information? Well, our brain is AI. You have to feed it information. You only become better at detecting disease by looking, and looking, and looking. You're looking at health, at gross disease, at mild, moderate and initial disease, and your brain is the AI.

It's taking that information and layering it each time you see it. And the beauty of your brain is that it also takes into account all the patient variables. AI will start to do that too, of course it will, but it needs to be fed. The human brain is doing that every day clinically, so don't underestimate it.

Don't be frightened to start with things that are a bit obvious. You might say, "There's no point using the scanner on this." Well, there is, because your brain is assimilating that information.

JAZ:
It's the same as when an experienced dentist and a baby dentist look at the same radiograph and interpret it completely differently.

PROF AVIJIT BANERJEE:
Absolutely.

JAZ:
The experienced dentist has operated on that exact situation thousands of times, and they know that what we're seeing is going to be a lot more extensive, for example, while the younger colleague may not appreciate it. So it's the same thing. I think that's a great way to use that technology if you're new to it.

PROF AVIJIT BANERJEE:
Absolutely.

CHAPTER 9: PROXIMAL RESIN INFILTRATION: DETECT AND MANAGE, DON'T WATCH AND WAIT

JAZ:
We've had so many contributions from the community, with questions specifically for you. The flow of this two-part episode is that this first part is more about early caries, and then we'll talk about deep caries management in part two.

Going back to something interesting you said: when you have an earlier caries lesion, maybe just about cavitated, with micro-roughness or micro-cavitation, what's the role of interproximal resin infiltration? Does it have good enough evidence so far?

Is it something you use or have been advocating in your programmes? Because as a wet-fingered dentist looking at it, it looks very fiddly. I use the DMG product on anteriors for white patches, and I love it, but the big barrier to me using it interproximally is that it looks incredibly fiddly. I'd love to know what the latest research says. Is the juice worth the squeeze?

PROF AVIJIT BANERJEE:
Really important. Before I answer directly, let me take one step back, because it goes back to what I was hinting at the beginning about MIOC and turning the dial. For many people listening to this podcast, people of my age and older, and yourself for that matter, a lot of dentistry used the phrase "watch and wait" for early lesions.

I hate that phrase. Absolutely hate it. This idea that you've got early lesions, you tell the patient to use a toothbrush and toothpaste and crack on, and everything will be fine. Guess what? It's not. Then we get bigger holes in teeth, and then we start drilling, filling and billing.

It's a completely wrong healthcare system. What we should be doing is early detection and then management. Not watch and wait. Detect and manage. This is where all the technologies come in. Thirty or 40 years ago, we didn't have them. That's fair enough. We could only really see things at a relatively late stage.

Now we can see things earlier and earlier, and the danger is that everybody says, "If we see something early and treat it, that's over-treatment. Should we do it?" The analogy I've always used, because we're trying to put the mouth back in the body and link oral health to general health, is this. If I go to the doctor and they see my blood pressure going up,

what do they do? They don't just say, "Sort your diet out and take more exercise." Obviously they say that, but do they leave it at that and send you away? No. They start giving you blood pressure tablets. They start treating you. If you're pre-diabetic, or you've got early diabetes, what do they do?

Obviously they'll talk about primary prevention, diet, exercise and everything else. But they'll also start looking at medications to stop things getting worse quickly. In dentistry, what do we do? We just let the disease sit there.

Watch and wait. So that philosophy, in my humble opinion, is broken.

JAZ:
But to be fair to the profession, and I know you've thought about this too, the whole reason we do that is to try to work in a more minimally invasive way, because we know we can arrest lesions. So the intention is pure, isn't it?

PROF AVIJIT BANERJEE:
100%. I appreciate I may have come across as a little anti-profession. I didn't mean it that way.

JAZ:
No, of course not.

PROF AVIJIT BANERJEE:
I meant it the way you've just said. You're absolutely right. The problem is we put it back on the patient. Sadly, most patients don't brush their teeth well enough or moderate their diet well enough, and then lesions get worse.

And what do we end up doing? Drilling, filling and billing. Then we use the term "minimally invasive", but we're not actually being minimally invasive, because we should be managing non-operatively, which is what the patient does at home, managing micro-invasively, as I hinted a few minutes ago, and then being minimally invasive for the holes in teeth that are already there.

If we catch something early, in modern medicine, noting it and then doing nothing about it isn't acceptable anymore. The question is what we do. If people say, "We've got a white spot lesion, we can see it, so I'm going to drill a great big cavity and put a composite in," then clearly that's crazy.

The beauty now is... and I keep saying "now". I've been doing dentistry for 35 or 40 years, and it's only in the last 10 or 15 years that the materials and technologies have really blossomed. We now have a whole range of materials that are essentially topical or micro-invasive, which allow us to start treating.

To a lot of clinicians and patients, treatment means, "They're going to pick up a drill and do something." That's often what the word treatment equates to in dentistry. Not always, I know, but often, or at least that's the perception. What I'm arguing is that treatment doesn't have to be operative.

It can be micro-invasive. What we have there are resin-based sealants, fissure sealants for prevention, therapeutic sealants and sealant restorations. Then we have resin technologies. I'm not sure we can mention company names, but-

JAZ:
We can. It's fine.

PROF AVIJIT BANERJEE:
There's only one, really, which is DMG.

JAZ:
DMG proximal resin infiltration. Icon.

PROF AVIJIT BANERJEE:
Exactly. It's been around for a long time, and a lot of research has been done on it, both in the laboratory and clinically. Again, no one is arguing that you must use it in every single case. It's in our armamentarium, and it can work very effectively.

For those who aren't aware, the concept is that you have an early white spot lesion on the tooth. You put a very strong acid, basically hydrochloric acid, onto the tooth. It burns through the mineralised surface layer of the carious lesion and makes the pores in the enamel a bit bigger, allowing the resin to infiltrate and penetrate. Then you cure it with a light, and it basically seals up those holes.

That's the principle. There's plenty of evidence that, in the right patients and the right situations, it can work very effectively. So it's a big thumbs up. And you commented that it's fiddly. Everything in dentistry is fiddly until you're practised at it, isn't it?

JAZ:
Especially if it's proximal.

PROF AVIJIT BANERJEE:
Absolutely. But they have protocols and kits that allow you to do it. And the fact is, the first time you put rubber dam on, it was fiddly.

JAZ:
Oh, yeah.

PROF AVIJIT BANERJEE:
The first time you handled a bonding agent, it was fiddly, and so on. The more you do things, the less fiddly they become. So that's one area. We've got sealants, we've got resin infiltration, and I hinted at peptide technologies as well.

CHAPTER 10: THE SWEET SPOT: E1, E2, D1, AND SEALANT VS RESIN INFILTRATION

JAZ:
Can I just say, I'm so pleased you've educated me about the resin infiltration system and given it a thumbs up. I will use it.

I've been umming and ahhing about it, so it's great to have this vote of confidence. Your analogy with how we manage things in medicine made so much sense: being micro-invasive and managing things appropriately while we can.

It makes so much sense. But I'd like to hear whether you have guidelines. At what point is it too late for resin infiltration, so you've got to get a diamond bur out and cut a hole? And at what point is it too early, so you should consider fluoride varnish, SDF, or peptides, which you'll come to?

What's the sweet spot of diagnosis, clinically or radiographically, for this technology?

PROF AVIJIT BANERJEE:
The sweet spot is always difficult in this part of cariology, because we're talking about such subtle changes in the mouth. I'm sure your listeners know about E1, E2, D1, D2 and D3, the radiographic levels of lesions: outer enamel, inner enamel, then dentine split into thirds.

That's fine and great, assuming you've got really high-quality radiographs taken with perfect angulation. Then you can sometimes see that, which is amazing. But let's be honest: in real-life practice, can you always see the difference between E1 and E2 on a radiograph?

Of course you can't. It's no one's fault. That's just life. One thing I really want to get across today is that I'm a clinical academic. I've done lots of research, and still do. I've got PhD students looking at all the things we're talking about, and one part of my brain says, "Yes, this detail is brilliant, and we can do it."

We can give a sweet spot. We can say an E1 lesion should ideally be managed topically at home, with fluoride varnishes, toothpastes and so on. With an E2 lesion, you start to think potentially micro-invasive. You're still doing the other things, but for some lesions in that same patient, where they're not quite getting the brush on properly or are struggling, you might think of a sealant, resin infiltration or a peptide technology, for example.

JAZ:
Or say you see the patient, and at the next bitewing interval it's gone from E1 to E2, with the ideal technologies and so on. That's a potential situation for resin infiltration, for example.

PROF AVIJIT BANERJEE:
Absolutely. Exactly. Or whatever micro-invasive technology. But again, it all comes back to whether you have the skills to get your detection device to show these subtle changes. And this is where AI could potentially help in the future, in analysing radiographs, for example, or other technologies.

I use the word "help", not "do it for you", and that's a very key point. It's adjunctive. I'm a fan of AI in some ways and a sceptic in others. As long as it's adjunctive and learns with us, brilliant. It'll be absolutely brilliant. If it takes over and stops us thinking, then we've got a problem.

Because it will never beat the human brain, because of the variables we have to deal with. So, to answer your question, the sweet spot would be E1 to E2, if you like. But I repeat, that's easy to say in a podcast, or if you've got the perfect radiograph lined up.

If everybody audited their radiographs, could you honestly say you could see progression from E1 to E2 on a bitewing where you haven't standardised the angulation and everything else? It's always tricky.

JAZ:
What I want to establish is D1, but not cavitated.

PROF AVIJIT BANERJEE:
Correct.

JAZ:
D1, but not cavitated. Is that okay for resin infiltration?

PROF AVIJIT BANERJEE:
Right. Resin infiltration will only penetrate microns into the enamel.

JAZ:
Oh, okay.

PROF AVIJIT BANERJEE:
A certain number of microns, maybe 50 or 100. If you've got a lesion with a slight radiographic shadow into dentine at the EDJ, but no obvious cavitation,

maybe a slight shadowing through the occlusal surface, around the fissures, or classically, when the tooth is wet with saliva or water it looks normal, but when you blow the surface with your 3-in-1 it becomes frosty, then for those lesions you're probably looking at a therapeutic fissure sealant rather than resin infiltration.

JAZ:
But interproximally? Interproximally is harder.

PROF AVIJIT BANERJEE:
Much, much harder. Absolutely. Those were occlusal fissures. You're absolutely right: proximally it becomes more difficult, and then resin infiltration might be an option to try to seal off that surface. But always remember these things are never done in isolation.

They always go hand in hand with primary prevention: oral hygiene, fluoride toothpastes and all those things. So please remember that even though we're talking about things separately, for obvious reasons, the actual care given isn't separate.

CHAPTER 11: A WORD FROM OUR PARTNER: DMG ICON PROXIMAL OFFER, WEBINAR AND HANDS-ON COURSE

JAZ:
There we have it, guys. Now we know that proximal resin infiltration isn't just a fad. It's not just a fiddly gimmick. We should be offering it to our patients. So what's holding us back? What's been holding me back all this time? First, I don't have the training. Even though I can do the most intricate class II, I've just never used the kit.

I'm one of those people who wants to be shown how to do something once or twice before doing it myself, and that's held me back. I also didn't have confidence in the product, because I hadn't done my own research. That's why I asked Prof, "Is proximal resin infiltration any good, and should we be offering it?"

He gave it a huge thumbs up. That sparked my interest in learning about it, so I got in touch with DMG UK and asked whether they had any courses. They said no, they didn't. I begged them: "Please, can you put something on for us? And can you do something our international audience can also benefit from?"

I'm amazed they turned it around, but we've secured three things. Number one is a discount on your first order of Icon Proximal. It only works for one order per dental care professional, so don't be cheeky. It's a 20% discount on your first order of Icon Proximal.

Number two is a webinar with my good friend Cat Edney, called The Iconic Method. It's an introduction to Icon resin infiltration and modern enamel management, and you'll learn the principles of both vestibular and proximal resin infiltration. The webinar is on 24 June.

If you're watching this episode in the future, still go to the link and you'll be sent a replay of the webinar. And number three, for those of you who, like me, like to get hands-on, there's a full-day hands-on course on Saturday 4 July at Align Technology in Birmingham, UK, covering all things Icon resin infiltration, whitening and NIRI caries detection.

It's just £349, which is incredible for a full-day hands-on course. Many of you, and those of us who are international, will be just fine with the webinar on 24 June. But if you live locally and want to experience the magic of hands-on, you're probably better off going on the course.

To find out the details of all three, head over to protrusive.co.uk/dmg. That's protrusive.co.uk/dmg. Enter your details and DMG will send you all three things: the discount, should you want it, which will also be valid after the webinar and course, in case you want to wait until after the education to buy,

since some of you will be ready to crack on straight away, plus the webinar registration details and the in-person course details. So all three things are at protrusive.co.uk/dmg. Personally, I'm looking forward to learning so I can help my patients with a more proactive approach. I'll remind you again in the outro, but let's rejoin this episode with Prof Banerjee.

CHAPTER 12: AI CARIES DETECTION AND THE POWER OF TRIANGULATION

JAZ:
You've definitely been very clear and all-encompassing with that. We've got so many questions from the community, and one of them was about AI, so the next two questions will be on that, now that you've touched on it. This one's from Dr Yazan A Duadary, a long-term community member.

He asks, "How trustworthy is AI caries diagnosis on X-rays? I feel it over-analyses quite a bit." You've already said we can use it as data, but we can't let it take over.

PROF AVIJIT BANERJEE:
Yeah, take over.

JAZ:
You still have to use your judgement. But based on what you've seen, is it thumbs up or thumbs down for AI to help you?

PROF AVIJIT BANERJEE:
The difficulty is that AI is moving on at such a speed. It's incredible. And AI is only as good as the information it learns from. The better the information fed to an AI system, the better it will become.

That's simple rule number one. There's clearly plenty of AI software out there, AI apps that help read and assess radiolucencies, and if you're using them, that's great. But as I've always said, and said earlier, you also have to use the serotonin and acetylcholine in your own brain.

Because ultimately, AI isn't going to get sued. You will, if you get it wrong. So you've got to make the judgement call. Early caries detection especially is tricky. Let's cut to the chase: it's difficult. And what I try to teach my students and postgrads about early caries detection is that you've got to triangulate.

You asked me earlier whether one particular detection technology could be a game changer. Ultimately, maybe there will be one, who knows? But at the moment we have multiple bits of kit, and what you do is triangulate. You do your clinical examination carefully. You take good-quality radiographs, because they're still part of it.

You use your fluorescence detection devices, or whatever else. Then you can use AI on top of that if you want to. You're not going to do that for every single carious lesion in every tooth in every patient, of course. We're talking about the early ones, where you're thinking, "Ah, what do I do?

"Is it really a lesion? I'm not sure." When you're in doubt, that's when you triangulate. Then all you can do is give your best, learned opinion, based on your experience, your knowledge and the information you've got. And I tell you what, you can speak to any indemnity provider: no one has ever been sued for making an error if they've done all of that and their judgement call is ultimately proven wrong.

No one will get sued for that, because what else can you do? You can only go on the best information in front of you. But if you blindly take an AI, a piece of software, let it scan radiographs that aren't very good quality, and it starts telling you there are lesions where there aren't, or that they're bigger than they are, well, you're feeding it.

It's spewing out the information it's been fed. So ultimately, the human, the clinician, takes responsibility.

JAZ:
So what I've done so far, Prof, is this: if my principal decided to invest in AI for radiographs, I'd be all for it. It's just data, and it's nice to have data.

PROF AVIJIT BANERJEE:
100%.

JAZ:
And to triangulate with. I love that term, triangulate. But I'm not going out to buy it myself just yet, because although it's a good aid, it shouldn't replace your judgement and actions. If you have it, though, I love data personally. In occlusion I'm always gathering data.

One thing "triangulate" has reminded me of is a really good clinical lesson I learned when I was maybe three or four years qualified. My principal at the time, who I'm not going to name, was a lovely, lovely chap. You know him, actually. I'll tell you later.

He fed me so many patients. One patient he saw, he took a CBCT and found a radiolucency under a second premolar, and he referred them to me for an endo. I see this chap, and it's a completely unrestored tooth. I do my usual checks and my sensibility testing, and it's positive to Endo-Frost, a healthy positive.

So I sent the patient home: "I'm so sorry. I think everything's fine. I don't know what that is. We'll get it looked into. But this tooth does not need a root canal. You can go home." That's a great example. In a similar scenario, if you only use one data point and don't look at the others... On that day, it looks like I triangulated, and something didn't quite match up.

So if you rely on AI without looking in the mouth properly, actually drying it properly, wet, everything, then you will-

PROF AVIJIT BANERJEE:
Far more often. Absolutely. And again, think back to what you were taught. You don't treat a radiograph. You don't treat an investigation. Just because you see something on a radiograph or a CBCT or whichever investigation, you don't automatically treat it.

It's a red flag, a warning bell. You go back, reinvestigate the tooth, maybe check other aspects. Just look again, a bit harder, to double and triple check. I have this issue now with so many cases of cracked tooth syndrome. It's probably the stressed-out lifestyle everybody has, and you and I, and I'm sure all our listeners, know that cracked tooth syndrome can be an absolute nightmare to diagnose and manage, because-

JAZ:
And to communicate.

PROF AVIJIT BANERJEE:
And to communicate, because the patient's in exquisite pain, but there's barely anything wrong with the tooth apart from the most minuscule hairline crack, which you and I know deep down can't be causing that level of discomfort, so there has to be something else. But what do we do?

CHAPTER 13: JUSTIFY YOUR DECISIONS, TALK YOUR THINK, AND A PEPTIDE CLIFFHANGER

PROF AVIJIT BANERJEE:
All right, we're going off on a tangent, but bring it back to caries and it's the same principle. There are so many factors involved in management. I know we live in a world where we want guidelines, protocols and step-by-step guidance.

But as I get older, I tell my students, postgrads and others, "Do you know what? There are too many steps and protocols. People rely on them, and they switch their brains off." And don't forget, doing dentistry is difficult. That's why it takes five years, plus another five years of training afterwards, to

become, I'd say, even competent. There's a reason for that: it's damn difficult. And guess what? You're allowed to make mistakes, in the sense that, without a crystal ball, a decision may not turn out to be the right one. You might find out six months or a year later. I repeat what I said earlier: no one gets sued for that, as long as you made the decision justifiably, and I use that word a lot.

You have to justify, and that goes back to your care planning. You have to justify why you're doing things. The line I always use is that if you justify what you're choosing to do to yourself and to the patient in the chair, then you'll never have to justify it to the person wearing a wig and a gavel.

JAZ:
Writing all the justifications in your notes is a powerful thing.

PROF AVIJIT BANERJEE:
Absolutely.

JAZ:
And even to patients. I'm a big believer, inspired by my good friend Zarpankie, in "talk your think".

PROF AVIJIT BANERJEE:
Yeah, absolutely. Talk your think. Just talk out loud: what's going on, and what's your reasoning? It's a very, very powerful thing.

JAZ:
Right, even to patients. Now, you've answered comprehensively on AI, and I think we're both in agreement. But peptides I have very little knowledge of.

PROF AVIJIT BANERJEE:
Yeah.

JAZ:
They're part of micro-invasive care. Dr Jerry Brown asks, "What is the efficacy of the new peptide by..." He specifically said Vivadent, I think. They have something called Curodont. Is that the only one, or are there others out there? I know nothing about this, so please educate me.

PROF AVIJIT BANERJEE:
So again, it's another technology. It's not-

JAZ:
There we have it, guys. Part one ends on a cliffhanger. Thank you so much for listening all the way to the end. If you've already been using the term active surveillance and the frameworks Prof touched on, pat yourselves on the back.

You're a true modern dentist: minimally invasive and proactive. If not, now's a great time to change your protocols. If all you're offering is diet advice, fluoride varnish and then a restoration, there's so much more we could be doing, and that includes peptides. Everything about peptides, how they work and whether they're effective, we'll cover in part two.

For example, SDF, silver diamine fluoride: when should we use it instead of fluoride varnish? Are they as effective as each other? Is hydroxyapatite in toothpaste a good or a bad thing relative to fluoride? And everything from whether stepwise excavation is still a thing, to managing caries in the patient with extreme xerostomia.

That all awaits you in next week's episode. For now, don't forget to answer the quiz, get 80%, and our CPD queen, Mari, will send you a certificate. If you're not already part of our membership, you're missing out. You already enjoy our episodes, and you listen all the way to the end. That's a real achievement, so you deserve a place in our community.

Head over to protrusive.app, make an account, and you'll be racking up those CPD hours in no time at all. We're a PACE-approved provider of CE, recognised internationally. Inside our membership, we also turn the transcripts into premium notes, and all the promised papers go inside the premium version of the episode, in an area called the Protrusive Vault.

So do check out all the resources for this episode. And don't forget that special offer from DMG: a discount on their Icon Proximal product, limited to one order per dental professional. The website to order is protrusive.co.uk/dmg. That's protrusive.co.uk/dmg. I'll also put all the information about upcoming education on proximal infiltration in the show notes, 'cause it's all well and good having the kit, but how do you actually use it?

What are the little hacks for this fiddly area, this fiddly procedure? Any education, including upcoming courses, I'll put in the show notes, so don't forget to scroll down and check it out. The best place to get it all cleanly and nicely is, of course, the Protrusive Guidance app, so head over to protrusive.app, where we'll look after you.

Thank you so much, and I'll catch you same time, same place next week for part two. Goodbye for now.

FREQUENTLY ASKED QUESTIONS

QUESTION:
What is the difference between MIOC and MID?
ANSWER:
Prof explains that minimum intervention oral care (MIOC) is a whole-team delivery framework: prevention-based, person-focused, susceptibility-related and delivered by the oral healthcare team. It has four domains: identifying the problem, preventing lesions and controlling disease, minimally invasive operative dentistry, and reassessment and recall. Minimally invasive dentistry (MID) is just the third, operative domain.

QUESTION:
Why say active surveillance instead of monitoring?
ANSWER:
Prof describes "monitoring" as a passive throwaway term that means nothing to patients or policymakers. Active surveillance means periodically checking the patient's susceptibility to disease and looking for new, progressing or reversing lesions. Jaz adds that it reads better to patients, making them feel they are in safe hands, and he has already adopted it as his pearl.

QUESTION:
When should you pick up a drill for a carious lesion?
ANSWER:
Prof says what Jaz was taught still holds. He weighs three linked factors: cavitation, cleansability and activity. If there is an obvious hole the patient can't clean, the biofilm becomes cariogenic and the lesion stays active. On smooth surfaces such as buccal cervical lesions, he says saucerising the cavity so the patient can brush it may be enough.

QUESTION:
Is there one technology that can level up caries diagnosis?
ANSWER:
Prof's honest answer is not at the moment. He says no device, whether NIRI, fluorescence or optical, gives 100% sensitivity and specificity. His advice is to learn how your chosen technology works, understand its limitations, and calibrate yourself by scanning obvious lesions first, so your own brain learns to interpret what the device shows.

QUESTION:
Does proximal resin infiltration work?
ANSWER:
Prof gives it a big thumbs up, saying there is plenty of evidence that it can work very effectively in the right patients and situations. An acid opens the surface layer of an early lesion so resin can infiltrate the pores and be light-cured to seal them. He says it feels fiddly at first, like rubber dam once did.

QUESTION:
Which lesions suit resin infiltration rather than a fissure sealant?
ANSWER:
Prof suggests the sweet spot for micro-invasive options is around E1 to E2, accepting that this is hard to see on everyday radiographs. Because resin infiltration only penetrates microns into enamel, he would usually choose a therapeutic fissure sealant for an occlusal lesion with a slight shadow into dentine, while infiltration may suit proximal surfaces.

QUESTION:
How trustworthy is AI caries detection on radiographs?
ANSWER:
Prof says AI is only as good as the information it learns from, and poor-quality radiographs will give misleading results. He sees AI as adjunctive: helpful if it learns with us, a problem if it stops us thinking. For uncertain early lesions, he advises triangulating clinical examination, radiographs, other detection devices and AI, with the clinician taking responsibility.

QUESTION:
What is salutogenesis?
ANSWER:
Prof describes salutogenesis as focusing on promoting health and positive solutions rather than problems. In practice, he suggests changing the question from "What's the matter with you?" to "What matters to you?" He says this supports shared decision-making and behaviour change, and links each decision in a personalised care plan back to what matters to the patient.

ABOUT THE GUEST

Prof Avijit Banerjee is professor of cariology and operative dentistry at the Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, and an honorary consultant in restorative dentistry at Guy's and St Thomas' hospitals. He is an honorary clinical adviser to the Chief Dental Officer for England, the first dean of the Faculty of Dentistry at the College of General Dentistry, president of the British Society for Oral and Dental Research, oral and dental specialist lead for the NIHR South London Research Delivery Network, and editor-in-chief of the British Dental Journal portfolio.